Ipamorelin Dose Reference Table

Pre-calculated for 5mg vial + 2ml BAC water = 2500 mcg/ml concentration.

Dose (mcg) Inject Volume (ml) Syringe Units (100u)
100mcg 0.04 ml 4 units
150mcg 0.06 ml 6 units
200mcg 0.08 ml 8 units
250mcg 0.10 ml 10 units
300mcg 0.12 ml 12 units
500mcg 0.20 ml 20 units

About Ipamorelin

Ipamorelin is a synthetic pentapeptide and selective growth hormone secretagogue belonging to the GHRP (growth hormone-releasing peptide) class. It was developed in the 1990s and is frequently studied for its ability to stimulate growth hormone release from the pituitary gland with a high degree of selectivity. Unlike older GHRPs such as GHRP-6, Ipamorelin is notable in research contexts for producing minimal elevations in cortisol, prolactin, or ACTH — making it one of the cleaner GHRPs in terms of selectivity.

Ipamorelin acts on the ghrelin receptor (GHS-R1a) in the hypothalamus and pituitary gland, mimicking the action of the endogenous hormone ghrelin to trigger a pulsatile release of growth hormone. Researchers commonly study it in protocols that mirror the body's natural GH pulse patterns, often administering it two to three times per day. Its short half-life of approximately 2 hours means that each injection produces a discrete GH pulse rather than sustained elevation.

In research literature, Ipamorelin is frequently co-administered with GHRH peptides such as CJC-1295 or Sermorelin, as the two classes of peptides are believed to act synergistically through separate receptor pathways — GHRP at the ghrelin receptor and GHRH at the GHRH receptor. Typical research vial sizes are 5mg, reconstituted in 2ml bacteriostatic water to yield a working concentration of 2500 mcg/ml.

Frequently Asked Questions

In research settings, Ipamorelin is commonly studied at doses ranging from 100mcg to 300mcg per administration. A frequently referenced dose in research protocols is 200mcg, administered two to three times daily.
A standard reconstitution for a 5mg Ipamorelin vial uses 2ml of bacteriostatic water, yielding a concentration of 2500 mcg/ml. Inject the BAC water slowly down the side of the vial and gently swirl — never shake.
With a 5mg vial reconstituted in 2ml BAC water (2500 mcg/ml), a 200mcg dose equals 0.08ml, which corresponds to 8 units on a standard 100-unit (U-100) insulin syringe.
Ipamorelin has a relatively short half-life of approximately 2 hours. This short duration is why research protocols often administer it multiple times throughout the day to maintain consistent receptor stimulation.
Yes. Ipamorelin is frequently studied in combination with GHRH-class peptides such as CJC-1295 or Sermorelin. The combination is researched because GHRP and GHRH peptides are thought to act synergistically on growth hormone release through complementary receptor pathways.